These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 30420258

  • 1. Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction.
    Yu L, Zhou L, Li Q, Li S, Luo X, Zhang C, Wu B, Brooks JD, Sun H.
    J Pediatr Urol; 2019 Feb; 15(1):44.e1-44.e7. PubMed ID: 30420258
    [Abstract] [Full Text] [Related]

  • 2. Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.
    Gerber C, Harel M, Lynch ML, Herbst KW, Ferrer FA, Shapiro LH.
    J Pediatr Urol; 2016 Apr; 12(2):120.e1-7. PubMed ID: 26705690
    [Abstract] [Full Text] [Related]

  • 3. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy.
    Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, Paradies G, Caldarulo E, Infante B, Schena FP.
    Kidney Int; 2000 Jul; 58(1):182-92. PubMed ID: 10886563
    [Abstract] [Full Text] [Related]

  • 4. Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty.
    Cost NG, Noh PH, Devarajan P, Ivancic V, Reddy PP, Minevich E, Bennett M, Haffner C, Schulte M, DeFoor WR.
    J Urol; 2013 Oct; 190(4 Suppl):1462-7. PubMed ID: 23791906
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association between urinary biomarkers MMP-7/TIMP-2 and reduced renal function in children with ureteropelvic junction obstruction.
    Wang HS, Cho PS, Zhi H, Kostel SA, DiMartino S, Dagher AM, Davis KH, Cabour LD, Shimmel A, Lee J, Froehlich JW, Zurakowski D, Moses MA, Lee RS.
    PLoS One; 2022 Oct; 17(7):e0270018. PubMed ID: 35834547
    [Abstract] [Full Text] [Related]

  • 7. Urinary antimicrobial peptides: Potential novel biomarkers of obstructive uropathy.
    Gupta S, Jackson AR, DaJusta DG, McLeod DJ, Alpert SA, Jayanthi VR, McHugh K, Schwaderer AR, Becknell B, Ching CB.
    J Pediatr Urol; 2018 Jun; 14(3):238.e1-238.e6. PubMed ID: 29706289
    [Abstract] [Full Text] [Related]

  • 8. Impact of successful pediatric ureteropelvic junction obstruction surgery on urinary HIP/PAP and BD-1 levels.
    Gupta S, Nicassio L, Junquera GY, Jackson AR, Fuchs M, McLeod D, Alpert S, Jayanthi VR, DaJusta D, McHugh KM, Becknell B, Ching CB.
    J Pediatr Urol; 2020 Oct; 16(5):592.e1-592.e7. PubMed ID: 32278658
    [Abstract] [Full Text] [Related]

  • 9. Urinary carbohydrate antigen 19-9/creatinine ratio: A non-invasive marker for follow-up of unilateral ureteropelvic junction obstruction in children.
    Alizadeh F, Taefnia AM, Haghdani S.
    J Pediatr Urol; 2018 Feb; 14(1):62.e1-62.e4. PubMed ID: 29079483
    [Abstract] [Full Text] [Related]

  • 10. Role of urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL), Monocyte Chemoattractant Protein-1(MCP-1), and Interleukin-6(IL-6) as biomarkers in pediatric patients with hydronephrosis.
    Suchiang B, Pathak M, Saxena R, Sharma S, Mittal A, Nayak S, Jadhav A, Rathod K, Sinha A.
    Pediatr Surg Int; 2022 Nov; 38(11):1635-1641. PubMed ID: 36057907
    [Abstract] [Full Text] [Related]

  • 11. A novel urinary biomarker protein panel to identify children with ureteropelvic junction obstruction - A pilot study.
    Devarakonda CKV, Shearier ER, Hu C, Grady J, Balsbaugh JL, Makari JH, Ferrer FA, Shapiro LH.
    J Pediatr Urol; 2020 Aug; 16(4):466.e1-466.e9. PubMed ID: 32620509
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis.
    Madsen MG, Nørregaard R, Palmfeldt J, Olsen LH, Frøkiær J, Jørgensen TM.
    J Pediatr Urol; 2013 Dec; 9(6 Pt A):838-45. PubMed ID: 23228281
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association between NDUFS1 from urinary extracellular vesicles and decreased differential renal function in children with ureteropelvic junction obstruction.
    Bu L, Zhang L, Wang X, Du G, Wu R, Liu W.
    BMC Nephrol; 2024 May 08; 25(1):158. PubMed ID: 38720274
    [Abstract] [Full Text] [Related]

  • 17. The role of renal biomarkers to predict the need of surgery in congenital urinary tract obstruction in infants.
    Kostic D, Beozzo GPNS, do Couto SB, Kato AHT, Lima L, Palmeira P, Krebs VLJ, Bunduki V, Francisco RPV, Zugaib M, Dénes FT, de Carvalho WB, Koch VHK.
    J Pediatr Urol; 2019 May 08; 15(3):242.e1-242.e9. PubMed ID: 30979613
    [Abstract] [Full Text] [Related]

  • 18. Urinary cytokine profiles in unilateral congenital hydronephrosis.
    Taranta-Janusz K, Wasilewska A, Dębek W, Waszkiewicz-Stojda M.
    Pediatr Nephrol; 2012 Nov 08; 27(11):2107-2113. PubMed ID: 22744767
    [Abstract] [Full Text] [Related]

  • 19. Urinary epidermal growth factor, monocyte chemotactic protein-1, and β2-microglobulin in children with ureteropelvic junction obstruction.
    Bartoli F, Penza R, Aceto G, Niglio F, D'Addato O, Pastore V, Campanella V, Magaldi S, Lasalandra C, Di Bitonto G, Gesualdo L.
    J Pediatr Surg; 2011 Mar 08; 46(3):530-6. PubMed ID: 21376205
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor-beta1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up.
    Sager C, Lopez JC, Duran V, Burek C, Perazzo E.
    Int Braz J Urol; 2009 Mar 08; 35(3):315-23; discussion 323-5. PubMed ID: 19538767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.